Management of Persistent Pleural and Parenchymal Opacities

Initial Assessment and Diagnostic Approach

The American College of Radiology recommends that persistent pleural and parenchymal opacities in the right lung base on chest X-ray warrant further investigation as they may represent various pathologies, including parapneumonic effusion, empyema, or other pleural or parenchymal diseases 1
Chest X-ray has a limited ability to differentiate between various causes of pleural and parenchymal opacities, with a correct diagnosis rate of only 48-87% when attempting to make a "confident" diagnosis based on radiographs alone 2
The American College of Radiology suggests that radiographs are also limited in their ability to distinguish empyema from early parapneumonic or other non-infectious causes of effusions 3

High-resolution CT (HRCT) scanning allows for detailed evaluation of the lung parenchyma and should be obtained at 2-cm intervals to allow more accurate assessment of pleural abnormalities and other findings 2
Ultrasound is useful for identifying exudative pleural effusions and can help guide diagnostic aspiration if required, with echogenic effusions caused by exudates and homogeneous echogenic effusions possibly due to empyema 4

Diagnostic thoracentesis should be performed to analyze the fluid for biochemical parameters, microbiological studies, and cytology if a pleural effusion is present 4
The American Thoracic Society recommends that frank pus (empyema) requires chest tube drainage without additional biochemical tests, while complicated parapneumonic effusions require drainage 4
Simple parapneumonic effusions may resolve with antibiotics alone, according to the British Thoracic Society 4

If drug-related pneumonitis is suspected, management typically involves drug withdrawal and, in moderate to severe cases, corticosteroid therapy, as recommended by the American College of Chest Physicians 5
If interstitial lung disease is suspected, HRCT findings typically include evidence of fibrosis, and management depends on the specific type of interstitial lung disease identified, according to the European Respiratory Society 2

Follow-up chest imaging is useful to assess changes in findings and response to treatment, with the timing of follow-up scans based on clinical context, including severity of symptoms and clinical course, as recommended by the American College of Chest Physicians 5
A normal chest radiograph cannot exclude microscopic evidence of interstitial lung disease on lung biopsy, and overlying pleural disease may not allow clear interpretation of parenchymal markings on chest radiographs, making CT essential, according to the American Thoracic Society 2